Team:EPF Lausanne/Calendar/6 August 2013

From 2013.igem.org

(Difference between revisions)
Line 12: Line 12:
'''Nanoparticles'''
'''Nanoparticles'''
-
- Purification of the digested GPs.
+
<br>- Purification of the digested GPs.
-
- Measurement of the GPs+dye with Dynamic Light Scattering (DLS). Results: good, we get some 10nm particles and a few 100nm. We hope they are nanoparticles and not artifacts.  
+
<br>- Measurement of the GPs+dye with Dynamic Light Scattering (DLS). Results: good, we get some 10nm particles and a few 100nm. We hope they are nanoparticles and not artifacts.  
-
- Started a new stock of GPs; made the gelatin solution, cross-linked with glutaraldehyde and stirred overnight.
+
<br>- Started a new stock of GPs; made the gelatin solution, cross-linked with glutaraldehyde and stirred overnight.
{{Template:EPFL2013Footer}}
{{Template:EPFL2013Footer}}

Revision as of 20:34, 2 October 2013

Taxi.Coli: Smart Drug Delivery iGEM EPFL

Header

Cell Surface Display

Gibson Transformation:
Transformation of HB5α competent cells with INP_Strep-Dead gibson product previously obtained.
Overnight incubation of the transformed cells in chloramphenicol paltes at 37°C.

Overnight Inoculation in LB + Amp medium of colonies from BBa_K283010 (05.08.10) ampicillin plates.


Nanoparticles


- Purification of the digested GPs.
- Measurement of the GPs+dye with Dynamic Light Scattering (DLS). Results: good, we get some 10nm particles and a few 100nm. We hope they are nanoparticles and not artifacts.
- Started a new stock of GPs; made the gelatin solution, cross-linked with glutaraldehyde and stirred overnight.